These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 16114114)

  • 21. Sequential staining improves detection of CCR2 and CX3CR1 on monocytes when simultaneously evaluating CCR5 by multicolor flow cytometry.
    Jalbert E; Shikuma CM; Ndhlovu LC; Barbour JD
    Cytometry A; 2013 Mar; 83(3):280-6. PubMed ID: 23426986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of HIV type 1 primary isolates to human anti-CD40 antibody-mediated suppression is related to coreceptor use.
    Abayneh SA; Ellmark P; Karlsson U; Andersson H; Borrebaeck CA; Karlsson I; Fenyö EM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):447-52. PubMed ID: 18373433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes.
    Desmetz C; Lin YL; Mettling C; Portalès P; Noël D; Clot J; Jorgensen C; Corbeau P
    Clin Immunol; 2007 May; 123(2):148-54. PubMed ID: 17363330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirement of multiple phage displayed peptide libraries for optimal mapping of a conformational antibody epitope on CCR5.
    O'Connor KH; Königs C; Rowley MJ; Irving JA; Wijeyewickrema LC; Pustowka A; Dietrich U; Mackay IR
    J Immunol Methods; 2005 Apr; 299(1-2):21-35. PubMed ID: 15914189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
    Xiang SH; Farzan M; Si Z; Madani N; Wang L; Rosenberg E; Robinson J; Sodroski J
    J Virol; 2005 May; 79(10):6068-77. PubMed ID: 15857992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
    Qin S; Rottman JB; Myers P; Kassam N; Weinblatt M; Loetscher M; Koch AE; Moser B; Mackay CR
    J Clin Invest; 1998 Feb; 101(4):746-54. PubMed ID: 9466968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient chemokine receptor blockade does not prevent, but may accelerate type 1 diabetes in prediabetic NOD mice.
    Seifarth C; Mack M; Steinlicht S; Hahn EG; Lohmann T
    Horm Metab Res; 2006 Mar; 38(3):167-71. PubMed ID: 16673207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCR5 small-molecule antagonists and monoclonal antibodies exert potent synergistic antiviral effects by cobinding to the receptor.
    Ji C; Zhang J; Dioszegi M; Chiu S; Rao E; Derosier A; Cammack N; Brandt M; Sankuratri S
    Mol Pharmacol; 2007 Jul; 72(1):18-28. PubMed ID: 17392523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injury to research volunteers--the clinical-research nightmare.
    Wood AJ; Darbyshire J
    N Engl J Med; 2006 May; 354(18):1869-71. PubMed ID: 16672696
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults.
    Jacobson JM; Saag MS; Thompson MA; Fischl MA; Liporace R; Reichman RC; Redfield RR; Fichtenbaum CJ; Zingman BS; Patel MC; Murga JD; Pemrick SM; D'Ambrosio P; Michael M; Kroger H; Ly H; Rotshteyn Y; Buice R; Morris SA; Stavola JJ; Maddon PJ; Kremer AB; Olson WC
    J Infect Dis; 2008 Nov; 198(9):1345-52. PubMed ID: 18771406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological profile and clinical efficacy of fully human anti-IL-17RA antibody Brodalumab (LUMICEF
    Aono Y; Amano T; Matsudo H; Hirose S; Morishige T; Kikuta N; Okada H; Hamaura N
    Nihon Yakurigaku Zasshi; 2016; 148(4):205-215. PubMed ID: 27725569
    [No Abstract]   [Full Text] [Related]  

  • 32. Monoclonal antibody-assisted stimulation of adenosine A2A receptors induces simultaneous downregulation of CXCR4 and CCR5 on CD4+ T-cells.
    By Y; Durand-Gorde JM; Condo J; Lejeune PJ; Fenouillet E; Guieu R; Ruf J
    Hum Immunol; 2010 Nov; 71(11):1073-6. PubMed ID: 20732363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.
    Barassi C; Soprana E; Pastori C; Longhi R; Buratti E; Lillo F; Marenzi C; Lazzarin A; Siccardi AG; Lopalco L
    J Virol; 2005 Jun; 79(11):6848-58. PubMed ID: 15890924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2.
    Marini P
    Curr Opin Mol Ther; 2006 Dec; 8(6):539-46. PubMed ID: 17243490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new prospective against HIV infection: induction of murin CCR5-downregulating antibodies.
    Barassi C; Marenzi C; Pastori C; Longhi R; Lazzarin A; Lopalco L
    New Microbiol; 2004 Apr; 27(2 Suppl 1):85-94. PubMed ID: 15646069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CCR5, a new target of anti-HIV drugs].
    Han YX; Jiang JD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):635-9. PubMed ID: 14650176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of CCR5 in experimental autoimmune myocarditis and reduced severity induced by anti-CCR5 monoclonal antibody.
    Gong X; Feng H; Zhang S; Yu Y; Li J; Wang J; Guo B
    J Mol Cell Cardiol; 2007 Apr; 42(4):781-91. PubMed ID: 17362985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and clinical investigation of the relationship between CCR5 receptor occupancy and anti-HIV activity of Aplaviroc.
    Demarest JF; Sparks SS; Schell K; Shibayama S; McDanal CB; Fang L; Adkison KK; Shachoy-Clark A; Piscitelli SC
    J Clin Pharmacol; 2008 Oct; 48(10):1179-88. PubMed ID: 18676693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCR5 antagonists for the treatment of HIV.
    Barber CG
    Curr Opin Investig Drugs; 2004 Aug; 5(8):851-61. PubMed ID: 15600241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.